BioSpace News Archive

10x Genomics, Inc. (Nasdaq: TXG), a life sciences leader focused on mastering biology, today announced a series of new product updates and technology demonstrations that will be presented at the 2023 Advances in Genome Biology and Technology (AGBT) General Meeting this week in Hollywood, Fla.

IgGenix, Inc., a pre-clinical biotechnology company taking a revolutionary approach to directly address allergic disease, today announced its first close on a $40M Series B financing to advance its lead program in peanut allergy to the clinic.

Vistagen (NASDAQ: VTGN) today announced it will host a conference call and webcast on Tuesday, February 7, 2023, at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to report financial results for its fiscal year 2023 third quarter ended December 31, 2022 and provide a corporate update.

ACG, a leading supplier of fully integrated manufacturing solutions to the global pharmaceutical and nutraceutical industries, is pleased to announce the appointment of Rafael Costa as Vice President for the Americas region.

Today Aluna, an award-winning connected care platform and at-home spirometer, announced a partnership with ModuleMD, ONC Certified EHR, leading practice management and EHR SaaS solution for allergists and pulmonologists, to improve patient and provider access to the latest technology in lung health.

Vizgen Inc. will present new data supporting the exceptional sensitivity, biological accuracy, and specificity of the company’s MERSCOPE™ Platform in addition to data describing the great quality performance using highly-multiplexed 500 gene panels for Neurobiology and Oncology applications at the Advances in Genome Biology and Technology (AGBT) 2023 General Meeting, occurring February 6-9, 2023.

BlueSphere Bio today announced Keir Loiacono, Chief Executive Officer of BlueSphere Bio, will present a corporate overview at the 2023 BIO CEO & Investor Conference held in New York City, NY from February 6-9, 2023.

SMi Trial™, ScienceMedia’s protocol compliance and risk-based training solution for clinical trials, now supports diversity in clinical trials.

Hillstream BioPharma, Inc. will be hosting a virtual R&D Day on Tuesday, February 14, 2023.

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced fourth quarter and full year results, as well as an update on U.S. companion animal diagnostic trends.